Covid 19 Research using Clinical Trials (Home Page)
C3+ Holter MonitorWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug1505 | MinnRAP Peer Support Program Wiki | 1.00 |
Correlated MeSH Terms (8)
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The study is a prospective clinical cohort study of consecutive patients hospitalized at all
hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The
investigators aim to examine if continuous ECG monitoring can be used to understand the
contribution of COVID-19 infection in the acute phase to the development of cardiac
arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the
investigators aim to examine if continuous ECG monitoring - alone and in combination with
biomarkers - can be used to detect early signs of cardiac complications and predict long-term
risk of cardiovascular morbidity and mortality following COVID-19 infection.
NCT04395664 COVID-19 Device: C3+ Holter Monitor
Primary Outcomes
Measure: In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis Time: 4 months
Measure: Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis Time: 4 months
Secondary Outcomes
Measure: Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis Time: 4 months
Measure: Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis Time: 4 months
Measure: Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis Time: 4 months
No related HPO nodes (Using clinical trials)